COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?
Pharmacology
[키워드] adjuvant
Allium
benefit/risk assessment
Clinical data
collected
conditions
coronavirus (2019-nCoV)
COVID-19
COVID-19 pandemic
COVID-19 patient
current
disease
drug
drugs
Echinacea
Efficacy and safety
EMA
Eucalyptus globulus
evaluated
Evidence
expected
Fever
flu
Frame
glycyrrhiza
healthy
Hedera helix
Herbal
herbal medicine
herbal medicines
IMPROVE
include
indicated
Magnolia
Medicine
Mikania
Mild
offer
Paracetamol
Patient
Pelargonium
positive
Preclinical
Prevent
recommendation
respiratory diseases
Result
safety margin
Sambucus
selected
Self-isolation
Self-management
Symptom
the WHO
therapeutic approaches
Treatment
underlying conditions
while
widespread
Zingiber
[DOI] 10.3389/fphar.2020.581840 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.581840 PMC 바로가기 [Article Type] Pharmacology